Persistent viral eradication or suppression through a defined course of Pegylated-interferon (PegIFN) or the administration of a long-term potent nucleot(s)ide analogues (NUCs) can impact positively the natural course of HBV infection by preventing disease progression. Despite the higher rates of off-therapy response achieved with PegIFN compared with NUC, its benefits are restricted to a subgroup of patients only. To increase the rates of patients who may benefit from PegIFN treatment, minimizing the adverse events, careful patient selections based on baseline features and on treatment HBsAg kinetics for individual treatment optimization are required.
Results of treatment of chronic hepatitis B with pegylated interferon / M. Viganò, G. Mangia, P. Lampertico. - In: CLINICS IN LIVER DISEASE. - ISSN 1089-3261. - 17:3(2013), pp. 425-443. [10.1016/j.cld.2013.05.004]
Results of treatment of chronic hepatitis B with pegylated interferon
M. ViganòPrimo
;G. MangiaSecondo
;P. Lampertico
2013
Abstract
Persistent viral eradication or suppression through a defined course of Pegylated-interferon (PegIFN) or the administration of a long-term potent nucleot(s)ide analogues (NUCs) can impact positively the natural course of HBV infection by preventing disease progression. Despite the higher rates of off-therapy response achieved with PegIFN compared with NUC, its benefits are restricted to a subgroup of patients only. To increase the rates of patients who may benefit from PegIFN treatment, minimizing the adverse events, careful patient selections based on baseline features and on treatment HBsAg kinetics for individual treatment optimization are required.| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S108932611300024X-main.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
1.15 MB
Formato
Adobe PDF
|
1.15 MB | Adobe PDF | [it] Default value: Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in AIR sono rilasciati con licenza CCO mentre i file delle pubblicazioni sono rilasciati con licenza CC BY-SA, salvo diversa indicazione. In caso di violazione di copyright, contattare l'assistenza di AIR




